Mumbai-based children's snack foods company, The Mumum Co, raised half a million dollars in an angel round of funding.The funds secured will be used for expansion in key metro and tier II cities, marketing, hiring and launching new and novel products in the healthy snacks category for children.The Mumum Company's 100 percent natural, healthy snacks for children are currently found across Mumbai, Bengaluru, and Pune at prominent retail chains like Godrej Nature's Basket, Foodhall, and Apollo Chemist as well as select neighborhood stores.The brand is set to expand to over eight more cities by the end of the year."When we became parents, we looked around for healthy, real, yet fun foods to feed our children. We soon realised that many parents were in the same boat as ours, with very few trustworthy options available. The "very, very, very real" nature of Mumum Co products comes from our conscious effort to feed our kids with 100 percent natural and nourishing foods to help their little ..
Skin is the most sensitive part of outer body, so for having the desired beautiful skin, one needs to treat it with more care. Natural ingredients have their own specialty and can work wonders if used religiously, say experts.
A liver transplant for cancer-stricken ex-Barcelona footballer Eric Abidal was carried out according to the law, Spanish health authorities said Tuesday, dismissing reports of organ trafficking. The transplant "took place according to the law in place and good clinical practice," said a statement from the Spanish health ministry's body responsible for monitoring organ donations. It noted the Barcelona clinic where the transplant took place had the birth certificates and other documents of both the organ recipient and the donor. Health authorities launched an investigation into allegations that Abidal's organ transplant may have been illegal. Online newspaper El Confidencial said earlier this month that wiretaps from a probe into corruption involving then-Barcelona president Sandro Rosell indicated that the club may have illegally procured a liver for Abidal. Rosell denied the report in an interview published by El Mundo on Tuesday. Abidal, a former France international, received a ...
A magnetic wire used to snag hard-to-capture tumour cells from blood vessels could prove to be a swift and effective tactic for early cancer detection, scientists say. The wire, which is threaded into a vein, attracts special magnetic nanoparticles engineered to glom onto tumour cells that may be roaming the bloodstream if you have a tumour somewhere in your body. With these tumour cells essentially magnetised, the wire can lure the cells out of the free-flowing bloodstream using the same force that holds family photos to your refrigerator. The technique could even help doctors evaluate a patient's response to particular cancer treatments: If the therapy is working, tumour-cell levels in the blood should rise as the cells die and break away from the tumour, and then fall as the tumour shrinks. "It could be useful in any other disease in which there are cells or molecules of interest in the blood," said Sam Gambhir, a professor at Stanford University in the US. "For example, let's say .
ZURICH (Reuters) - Swiss drugmaker Roche's hopes of recapturing lost ground in the generics-flooded influenza market got a boost after a late-stage study showed its new medicine reduced symptoms in people at high risk of complications.
Severe infections during childhood that lead to hospitalisations could lower academic performance in adolescence, a new study has found.
Cadila Healthcare advanced 2.43% to Rs 358.55 at 15:12 IST on BSE after the company announced that it has received final approval from the USFDA for Clindamycin Phosphate Topical Solution USP.
Administering a therapy using DNA-based compounds could extend survival and reverse signs of neuromuscular damage in animals of inherited amyotrophic lateral sclerosis (ALS), finds a study.
Scientists have found that multiple sclerosis (MS) may be identified at least five years earlier as the patients were more likely to undergo treatments for nervous system disorders like pain or sleep problems, according to a study.
Being in a bad mood can help some people's executive functioning, such as their ability to focus attention, manage time and prioritise tasks, according to a study. The study, published in the journal Personality and Individual Differences, also found that a good mood has a negative effect on executive functioning in some cases. Researchers at the University of Waterloo in Canada explored whether our emotional reactivity shaped how mood influences the kinds of thinking skills we need to navigate the demands and stresses of day-to-day life. The study included 95 participants, each of whom completed nine distinct tasks and questionnaires that measure the interplay of mood, emotional reactivity and various working memory and analytic challenges. Emotional reactivity refers to the sensitivity, intensity and duration of our emotional responses associated with our mood. "Our results show that there are some people for whom a bad mood may actually hone the kind of thinking skills that are ...
With an aim to tap the huge market potential in pharmaceutical and allied industries, a Gujarat-based university has collaborated with a leading American school of management to launch a specialised masters programme in business administration. The Ahmedabad University in collaboration with the Rady School of Management at the University of California San Diego yesterday announced the launch of a Global Executive MBA Degree in Pharmaceutical Management to professionals employed in pharma and allied industries. The university said in a statement that there was a need in the industry to redefine existing practices, introduce new technology and models and cultivate performance driven culture that delivers improved quality of access, care and solutions. "As India becomes a global pharma hub, it is imperative that the leaders, managers and employees of companies in the sector sharpen their technological, scientific, and management acumen," said Professor Pradeep Khosla, Chancellor, ...
ZURICH (Reuters) - Swiss drugmaker Roche's hopes of regaining ground in the influenza market have been boosted after a late-stage study showed its investigational drug baloxavir marboxil reduced symptoms in people at high risk of complications.
Medical Technology Association of India (MTaI), an association of research-based medical technology companies who have made significant investments in India in R&D and manufacturing, today organized 'MTaI Medical Packaging Seminar' to educate medical device professionals in the country on new Medical Device Rules introduced in Europe, which could impact exports to that continent.According to the regulatory experts at the seminar, medical device regulations are changing steadfastly around the world and many of these new guidelines will impact packaging. They stated that these new changes are enabled to develop packaging that will help end-users in ensuring the safe use of sterile medical devices.Thierry Wagner, Director - Regulatory Affairs, E. I. DuPont de Nemours (Luxembourg) detailed the features and the current implementation issues of EU's new Medical Device Regulations (MDR) adopted in April 2017. He also mentioned new directives and regulations evolving in the Association of
Indo UK Institute of Health (IUIH) aims to provide affordable, available and accountable healthcare in India via 11 medicities and 5000 planned Indo UK clinics.The IUIH facilities will have global expertise both in operations and research from their collaboration with the UK's National Health Service (NHS), partnerships with leading international healthcare industry companies and international partners in research, education, manufacturing, and healthcare delivery.The IUIH ecosystem will be built up over 20 years, serving close to 100 million people by 2025 and over 660 million people by 2037.IUIH is committed to a comprehensive digital strategy across all areas of operation and the utilization of leading-edge healthcare technology solutions for improving clinical quality and safety, continuity of care, patient outcomes, patient experience, and operational efficiency. Indo UK Health Innovation (IUHI), the technology arm of IUIH, will build digital assets and technological ...
Anti-obesity drug derived from chili peppers caused long term weight loss and improved metabolic health in mice eating a high fat diet.The University of Wyoming School of Pharmacy study found the novel drug, Metabocin, was based on capsaicin - the compound that gives chili peppers their spicy burn.It was designed to slowly release capsaicin throughout the day so it can exert its anti-obesity effect without producing inflammation or adverse side effects."We observed marked improvements in blood sugar and cholesterol levels, insulin response, and symptoms of fatty liver disease," reported Dr. Baskaran Thyagarajan, lead investigator, describing how Metabocin reversed many damaging effects of the high fat diet.The research team developed Metabocin, which can be taken orally, to target receptors called TRPV1 (transient receptor potential vanilloid subfamily 1) that are found in high numbers in fat cells. Stimulating the TRPV1 receptors causes white fat cells to start burning energy instead
Drug firm Zydus Cadila today said it has received final approval from the US health regulator to market Clindamycin Phosphate Topical Solution, used to treat acne. The company has received approval from the US Food and Drug Administration (USFDA) to market Clindamycin Phosphate Topical Solution USP (Cleocin T), 1 per cent, Zydus Cadila said in a BSE filing. Clindamycin is an antibiotic which works by stopping the growth of bacteria. It is used to treat acne and helps to decrease the number of acne lesions, it added. The company said it will manufacture the product at the group's topical manufacturing facility in Ahmedabad. The company has more than 204 approvals and has so far filed over 330 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04. Shares of the company's listed entity Cadila Healthcare were trading 2.27 per cent up at Rs 358 apiece on the BSE.
A novel drug based on capsaicin, the compound that gives chili peppers their spicy burn, causes long term weight loss and improves metabolic health in mice eating a high fat diet, a study led by an Indian origin researcher has found. The drug, Metabocin, was designed to slowly release capsaicin throughout the day so it can exert its anti-obesity effect without producing inflammation or adverse side effects, researchers from the University of Wyoming in the US said. "We observed marked improvements in blood sugar and cholesterol levels, insulin response, and symptoms of fatty liver disease," said Baskaran Thyagarajan, lead investigator, adding Metabocin reversed many damaging effects of the high fat diet. The team developed Metabocin, which can be taken orally, to target receptors called TRPV1 (transient receptor potential vanilloid subfamily 1) that are found in high numbers in fat cells. Stimulating the TRPV1 receptors causes white fat cells to start burning energy instead of storing
TIME CyberMedia, a Delhi based Market Research Company, is well known for innovative and accustomed services to the business needs.With the continued efforts towards the social responsibility and awareness among the society TIME CyberMedia organizes the conference on the various segments such as Education, Healthcare, etc. In continuation of the same efforts, TIME CyberMedia partnered with the renowned INDIA TODAY (Telecast Partner), Aaj Tak International (Media Partner) and Dilli Aaj Tak (Broadcast Partner) for the 3rd International Healthcare Awards, 2018 & Conference be carried out.Graced by the enthralling presence of the renowned Oncologist Padmshree Dr. J. K. Singh, Dr. Yoganand Shashtri, Former Speaker, Delhi Legislative Assembly, Shri Chetan Sharma, Former Cricketer and Member of DDCA along with Shri Basant Kumar, Ret. IAS & Shri Surender Mahrolia jee, Political Activist the exclusive program for Elite individuals and Institutions from Healthcare fraternity ranging ...
Turns out, severe infections that have led to hospitalisation during childhood are associated with lower school achievement in adolescence.According to a new research conducted at Wolters Kluwer Health, higher numbers of hospitalizations for infections are associated with a reduced probability of completing ninth grade, as well as with lower test scores.The study included nationwide data of several children. The researchers looked at two measures of childhood infections i.e. hospital admission for infections, an indicator of moderate to severe infections, and prescriptions for anti-infective drugs (such as antibiotics) in primary care, reflecting less-severe infections.These infection measures were then analyzed for their association with two measures of later school achievement, completing ninth grade and average scores on the final ninth-grade school examinations.Any hospital contact for infections was associated with a reduction in the odds of completing ninth grade. The more ...